Technician involvement in modernising a clean room
|
Rebuilding the West Middlesex University Hospital provided the ideal opportunity to modernise the clean room. A pharmacy technician was among the key members of the team responsible for ensuring that the new facilities met the needs of staff and supported the licensing of the unit |
|
Focus on technicians series |
Miss Taylor is senior technician, technical services and Mrs
Armstrong is principal pharmacist at the cancer services and technical services unit at West Middlesex University Hospital, Isleworth, London
|
Delivering patient-centred, high-quality health care was among the
reasons to install a modern clean room, with isolators rather than
laminar flow cabinets, at the West Middlesex University Hospital when
it was being newly built as a result of a PFI (private finance initiative)
project.

Marion Taylor (right) and Clarissa Armstrong standing outside
the newly-built West Middlesex University Hospital |
Among the key members of the team responsible for planning, commissioning
and validating the new facilities was the senior technician at the
hospital’s technical services unit. This article explains the
process adopted, highlighting the roles carried out by lead pharmacy
technical services staff, according to the following action plan: · Managing preliminary issues
· Setting up a project team
· Designing and constructing the
clean room
· Commissioning, validating and
handing over the clean room
· Training staff and implementing new ways of working
· Passing MHRA (Medicines and
Healthcare products Regulatory Agency) inspections
Preliminary issues Plans for the clean room were drawn up as part of the tendering process
to award the PFI contract for the new hospital. Meetings with the NHS
quality assurance specialist pharmacist for London and inspectors from
the Medicines and Healthcare products Regulatory Agency revealed that
there were issues with these plans. In particular, important information
required to license the facilities (such as details about the ducting
systems to be used, isolator types, room pressures and room grades)
was not included.
The way forward was, therefore, to engage trust executives to support
the modification of the plans, advise the PFI contractors of the issues
and suggest that a specialist cleanroom firm be brought onboard to
help design and commission the facilities.
Project team
Having brought onboard a specialist firm, a project team to manage
the design and installation of the clean room was set up. This comprised
the following members:
· Principal pharmacist, cancer services and technical services unit
(project leader)
· Quality assurance specialist pharmacist for London (lead adviser)
· Senior technician, technical services (technical officer)
· Senior staff member from Daws
Technologies, specialist clean room
contractor (design contractor)
· Senior manager of Bouygues (main PFI contractors for hospital)
Clean room design
The initial plans for the clean room required a certain amount of
additional work before they could support the licensing of the facility.
These designs were also complicated and it was believed that they could
be simplified to ensure that the resulting clean room would be user-friendly,
with good product workflow and comply with the European Union guide
to good manufacturing practice.
Members of the project team therefore put together a specification
that
incorporated the main design features of the new clean room. An appreciation
of current practice, the range of products manufactured and capacity
played an important part in the final design. Examples of these features
are set out in Panel 1 (p 254).
Panel 1: Design requirements for the new clean room

The assembly room, part of the newly-built clean room, designed
so that pressure differentials run from rooms of high to low
classification |
· Air handling unit and alarm system to be dedicated specifically
to the clean room to support the ducted system for the isolators
· To be one positive pressure isolator for making TPN and three negative
pressure
isolators for making CIVAS and cytotoxic chemotherapy products. Isolator
cabinets to support shutdown leak testing and airflow rate and HEPA
filter pressure
differential monitoring and to have a pressure loss alarm
· Room pressure differentials to run from rooms of higher classification
to lower
classifaction — ie, rooms housing isolators for cytotoxic reconstitution
(highest
classification and pressure) to rooms where operators “gown
up” to rooms where operators assemble the items they need to
make the product (“assembly”) to rooms at ambient pressure
· Pressure differentials across a HEPA filter in both cytotoxic and
assembly areas are to be monitored
· All pressure readings to be displayed on magnahelic gauges contained
within the control box located in the assembly room of the clean
room
· Room grades to be sufficient to support the use of turbulent isolator
technology
· All materials including power switches, interlock transfer hatches,
names plates, vinyling, shelving, workbenches and furniture are to
be of clean room type
· Power to the facility to be connected to an emergency supply as
well as to main
generators |
Building work then went ahead, according
to the detailed specification. Every stage in the construction process
was monitored closely, with
the principal pharmacist, senior technician and quality assurance
officer making regular site visits. Clean room commissioning The next stage was the commissioning of the isolators and clean room.
This
needed to be done to strict timescales, so that the new facilities
would already be running when the old ones were closed down. It was
also important that the handover of the facilities fitted in with the
handover timetable agreed on a hospital-wide basis.
The commissioning process included, for example, monitoring the critical
performance criteria (ie, room pressure, air changes, temperature and
humidity) and carrying out the environmental (eg, using settle plates)
and physical monitoring required for validation. Monitoring of the
critical performance crieria was performed automatically by the building
maintenance system (an electronic system controlled from the plant
room). In order to comply with licensing requirements, uninterrupted
monitoring periods are required, and so access into the new clean room
was restricted to the principal pharmacist, senior management from
the PFI company and to those performing the environmental and physical
assessments (ie, the senior technician).
It was also necessary to compile a validation master plan (VMP) — a
quality assurance document providing evidence that the clean room would
perform consistently to defined licensing standards. It comprises design,
installation, operation and performance documents, put together by
the relevant people (for example, the isolator manufacturers provide
the necessary information and protocols about the isolator installation)
and signed off appropriately at each stage.
In preparation for handover, the new facilities were cleaned by the
specialist clean room contractor and then by lead technical support
staff. One of the final stages of commissioning was the MHRA inspections
(see later).
All the time that the commissioning of the new facilities was underway,
existing production services (at a different building at the same hospital
site) were maintained. This required the staff involved to organise
their time meticulously.
Staff training
There were two main aspects in training — instruction on how
to use isolators (as opposed to laminar flow cabinets, with which the
technical staff were familiar) and a more comprehensive training plan
of performance to standard operating procedures (SOPs) relating to
good manufacturing practice.
Isolator training was initially provided by the manufacturers, with
input from the quality assurance officer. This formed the basis of
more comprehensive training, which was carried out by the senior technician
and managed by the principal pharmacist, once the standard operating
procedures for the isolators and new ways of working had been compiled.
In order to devise the comprehensive training plan, the quality assurance
pharmacist, senior technician and principal pharmacist visited a similar
NHS clean room in Woolwich, London that had been recently commissioned
and met up with their lead technical staff.
MHRA inspections
Clearly, it was of upmost importance that the MHRA approved the transferral
of the “specials” license from the old facilities to the
new ones. The MHRA inspection to enable this to happen comprised the
checking of both the physical nature of the facilities and the supporting
documentation, which included the VMP, SOPs and other commissioning
and validation documents (such as the methods and results of the environmental
and physical monitoring and of the operator and isolator validations.)
It was the senior technician’s role to put together much of the
supporting documents and to assist the principal pharmacist in ensuring
that all members of the project team were in attendance at the relevant
inspections, depending on the skills required to support the MHRA licensing
requirements.
In all, three inspections took place before the clean room was licensed.
The need for further environmental and physical monitoring was among
the reasons that the facility was not licensed after the first and
second inspections. In addition, the retrospective pressure test decays
reflected some discrepancies between isolators (these were, however,
within limits and plans to increase the frequency of “leak testing” further
satisfied the MHRA that their requirements were met). The project team
also had to justify using turbulent isolators instead of the “old
technology” of laminar flow cabinets and for using negative pressure
isolators to prepare CIVAS (central intravenous additive service) products.
Conclusion
The opportunity to lead in a redevelopment project was an exciting
and challenging prospect for the whole project team, which provided
them with a great sense of achievement. Their experience shows that
it is important to work collaboratively, identify senior management
leads, develop a credible network, communicate the effects of proposed
actions to relevant staff and engage in training early in the process.
Most important of all, however, is to ensure that technical services
pharmacy staff are involved throughout the process, particularly during
the initial planning and designing stages.
“Focus on technician” articles
This series exists to report on how pharmacy technicians
are pushing forward their
traditional boundaries and making a full
contribution to the profession. Any
pharmacist or technician who is is involved in any new developments
in work
undertaken by technicians is asked to
consider writing an article for publication. Advice on the publication
process can be obtained by telephoning Hospital Pharmacist on
020 7572 2425/2419 or e-mailing gareth.jones@pharmj.org.uk |
|